141 related articles for article (PubMed ID: 20926229)
21. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A
Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
26. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
28. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Clark K; Monhollen L; Odunsi K; Lele S; Liu S
PLoS One; 2010 Nov; 5(11):e15415. PubMed ID: 21079744
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
[TBL] [Abstract][Full Text] [Related]
30. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
31. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
[TBL] [Abstract][Full Text] [Related]
33. Nodal metastasis in endometrial cancer.
Willis G; Misas JE; Byrne W; Podczaski E
Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
[TBL] [Abstract][Full Text] [Related]
34. p53 overexpression as a prognostic indicator in endometrial carcinoma.
Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G
Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
[No Abstract] [Full Text] [Related]
37. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.
Mamat S; Ikeda J; Enomoto T; Ueda Y; Rahadiani N; Tian T; Wang Y; Qiu Y; Kimura T; Aozasa K; Morii E
Oncol Rep; 2010 May; 23(5):1221-7. PubMed ID: 20372833
[TBL] [Abstract][Full Text] [Related]
39. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
